Elizabeth A. Brem

Elizabeth A. Brem

Hematology | Oncology

101 The City Drive South
Building 23
Orange, CA 92868

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

Comparison of Outcomes With Novel Versus Traditional Chemotherapy Regimens for Relapsed and Refractory Classical Hodgkin Lymphoma.

Comparison of Outcomes With Novel Versus Traditional Chemotherapy Regimens for Relapsed and Refractory Classical Hodgkin Lymphoma.

Journal: Clinical lymphoma, myeloma & leukemia

Published: December 13, 2025

Lite-BEAM expands autologous stem cell transplantation access for older or unfit patients with lymphoma.

Lite-BEAM expands autologous stem cell transplantation access for older or unfit patients with lymphoma.

Journal: Leukemia & lymphoma

Published: August 21, 2025

R-DA-EPOCH Versus DA-EPOCH-R: Impact of Chemoimmunotherapy Sequencing on Treatment Outcomes in Patients With Diffuse Large B-Cell Lymphoma.

R-DA-EPOCH Versus DA-EPOCH-R: Impact of Chemoimmunotherapy Sequencing on Treatment Outcomes in Patients With Diffuse Large B-Cell Lymphoma.

Journal: Clinical lymphoma, myeloma & leukemia

Published: May 06, 2025

Recurrent plasma cell myeloma with intracytoplasmic Auer rod-like inclusions after autologous hematopoietic stem cell transplantation.

Recurrent plasma cell myeloma with intracytoplasmic Auer rod-like inclusions after autologous hematopoietic stem cell transplantation.

Journal: International journal of clinical and experimental pathology

Published: February 14, 2025

Clinicopathological Prognostic Model for Survival in Adult Patients With Secondary Hemophagocytic Lymphohistiocytosis.

Clinicopathological Prognostic Model for Survival in Adult Patients With Secondary Hemophagocytic Lymphohistiocytosis.

Journal: European journal of haematology

Published: January 13, 2025

Clarithromycin, ixazomib, pomalidomide, dexamethasone for relapsed/refractory myeloma: survival and correlative analysis.

Clarithromycin, ixazomib, pomalidomide, dexamethasone for relapsed/refractory myeloma: survival and correlative analysis.

Journal: Blood neoplasia

Published: September 16, 2024

Upfront Management of Blastoid Variant Mantle Cell Lymphoma: Making the Case for 2nd/3rd-Generation Bruton Tyrosine Kinase Inhibitor-Based Therapies.

Upfront Management of Blastoid Variant Mantle Cell Lymphoma: Making the Case for 2nd/3rd-Generation Bruton Tyrosine Kinase Inhibitor-Based Therapies.

Journal: Cancer medicine

Published: June 13, 2024

A phase 1 study adding pitavastatin to venetoclax therapy in AML and CLL/SLL: a mechanism-based drug repurposing strategy.

A phase 1 study adding pitavastatin to venetoclax therapy in AML and CLL/SLL: a mechanism-based drug repurposing strategy.

Journal: Blood neoplasia

Published: April 05, 2024

CNS prophylaxis is (mostly) futile in DLBCL.

CNS prophylaxis is (mostly) futile in DLBCL.

Journal: BJC reports

Published: February 21, 2024

Looking to achieve cure the first time around for DLBCL patients who are older and/or with co-morbidities.

Looking to achieve cure the first time around for DLBCL patients who are older and/or with co-morbidities.

Journal: Seminars in hematology

Published: October 03, 2023

Anakinra versus etoposide-based therapy added to high-dose steroids for the treatment of secondary hemophagocytic lymphohistiocytosis.

Anakinra versus etoposide-based therapy added to high-dose steroids for the treatment of secondary hemophagocytic lymphohistiocytosis.

Journal: European journal of haematology

Published: May 11, 2023

Impact of Thiotepa-Based Autologous Hematopoietic Cell Transplantation in Primary Central Nervous System Lymphoma in First Complete Remission: A University of California Hematologic Malignancies Consortium Retrospective Analysis.

Impact of Thiotepa-Based Autologous Hematopoietic Cell Transplantation in Primary Central Nervous System Lymphoma in First Complete Remission: A University of California Hematologic Malignancies Consortium Retrospective Analysis.

Journal: Clinical lymphoma, myeloma & leukemia

Published: April 18, 2023

Showing 1-12 of 34

Last Updated: 09/26/2026